Useful markers for detecting minimal residual disease in cases of neuroblastoma

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 6, 2008, Pages 1071-1074

  Ootsuka, Susumu ^a   Asami, Satoru ^a   Sasaki, Takae ^a   Yoshida, Yoshikazu ^a   Nemoto, Norimichi ^a   Shichino, Hiroyuki ^a   Chin, Motoaki ^a   Mugishima, Hideo ^a   Suzuki, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Drosophia like 4; GD2 synthetase (GALGT); Minimal residual disease; Neuroblastoma; Neuroendocrine protein gene product 9.5; Tyrosine hydroxylase

Indexed keywords

GD2 SYNTHETASE; GENE PRODUCT; HU ANTIGEN; PROTEIN GENE PRODUCT 9.5; SYNTHETASE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN CELL; LEUKEMIA; LIVER CELL CARCINOMA; MINIMAL RESIDUAL DISEASE; NEUROBLASTOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM, RESIDUAL; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE; UBIQUITIN THIOLESTERASE;

EID: 45749109829     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1071     Document Type: Article

References (22)

1. Burchill S. A., Kinsey S. E., Picton S., Roberts P., Pinkerton C. R., Selby P., Lewis I. J., Med. Pediatr. Oncol., 36, 213-219 (2001).
2. Fukuda M., Miyajima Y., Miyashita Y., Horibe K., J. Pediatr. Hematol. Oncol., 23, 10-13 (2001).
3. Ghossein R. A., Rosai J., Cancer, 78, 10-16 (1996).
4. Reynolds C. P., Seeger R. C., J. Pediatr. Hematol. Oncol., 23, 150-152 (2001).
5. Ito R., Asami S., Kagawa S., Motohashi S., Shichino H., Chin M., Yoshida Y., Nemoto N., Mugishima H., Suzuki T., Biol. Pharm. Bull., 27, 315-318 (2004).
6. Hibi K., Westra W. H., Borges M., Goodman S., Sidransky D., Jen J., Am. J. Pathol., 155, 711-715 (1999).
7. Dalmau J., Furneaux H. M., Cordon-Cardo C., Posner J. B., Am. J. Pathol., 141, 881-886 (1992).
8. Furukawa K., Soejima H., Niikawa N., Shiku H., J. Biol. Chem., 271, 20836-20844 (1996).
9. Ruan S., Lloyd K. O., Cancer Res., 52, 5725-5731 (1992).
10. Chomczynski P., Sacchi N., Anal. Biochem., 162, 156-159 (1989).
11. Matthay K. K., Villablanca J. G., Seeger R. C., Stram D. O., Harris R. E., Ramsay N. K., Swift P., Shimada H., Black C. T., Brodeur G. M., Gerbing R., B., Reynolds C. P., N. Engl. J. Med., 341, 1165-1173 (1999).
12. Day I. N., Thompson R. J., FEBS Lett., 210, 157-160 (1987).
13. Jackson P., Thompson R. J., J. Neurol. Sci., 49, 429-438 (1981).
14. Wilkinson K. D., Lee K. M., Deshpande S., Duerksen-Hughes P., Boss J. M., Pohl J., Science, 246, 670-673 (1989).
15. Spataro V., Norbury C., Harris A. L., Br. J. Cancer, 77, 448-455 (1998).
16. Thompson R. J., Doran J. F., Jackson P., Dhillon A. P., Rode J., Brain Res., 278, 224-228 (1983).
17. Doran J. F., Jackson P., Kynoch P. A., Thompson R. J., J. Neurochem., 40, 1542-1547 (1983).
18. Schofield J. N., Day I. N., Thompson R. J., Edwards Y. H., Brain Res. Dev. Brain Res., 85, 229-238 (1995).
19. Day I. N., Hinks L. J., Thompson R. J., Biochem. J., 268, 521-524 (1990).
20. Parry D. A., Steinert P. M., Curr. Opin. Cell Biol., 4, 94-98 (1992).
21. Matsumura T., Shirai C., Yokota S., Sawada J., Shounikarinnshou, 50, 715-721, (1997).
22. Swerts K., De Moerloose B., Dhooge C., Vandesompele J., Hoyoux C., Beiske K., Benoit Y., Laureys G., Philippe J., Clin. Chem., 52, 438-445 (2006).